Literature DB >> 4030586

Effect of beta-adrenoceptor blockade on H+ and K+ flux in exercising humans.

A Katz, K Sahlin, A Juhlin-Dannfelt.   

Abstract

The effect of beta-adrenoceptor blockade (beta B) on muscle release and uptake of H+ and K+ in humans during maximal exercise has been investigated. Eight volunteers cycled intermittently at power outputs corresponding to 100% of maximal O2 uptake. Prior to exercise either propranolol (beta B) or saline (control) was infused into the femoral vein. Arterial and femoral venous blood samples were drawn at rest, during exercise, and during 30-min recovery. Peak arterial blood values for K+, lactic acid (LA), and base deficit (BD) (mean +/- SE) were respectively 5.5 +/- 0.1, 9.5 +/- 0.6, and 11.7 +/- 0.9 mmol/l during beta B and 5.1 +/- 0.1, 8.3 +/- 0.6, and 10.3 +/- 1.0 for control (P less than 0.05). The release of K+ from the working leg did not differ between treatments during exercise, but K+ uptake during late recovery (5-30 min) was slightly lower during beta B. Thus the higher arterial K+ levels during exercise (beta B) cannot be attributed to greater release by active muscle but are likely due to decreased K+ uptake by noncontracting muscle. Arterial-femoral venous differences for LA and BD did not differ significantly between treatments. Additionally LA exchange across the leg was similar to H+ exchange (arterial-femoral venous differences for BD) under all conditions. During early recovery (1-5 min), regardless of experimental treatment, BD levels iin arterial blood were higher than LA (P less than 0.05). These elevated BD levels may be due to unequal removal rates between LA and H+ equivalents by nonexercised tissue.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4030586     DOI: 10.1152/jappl.1985.59.2.336

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  14 in total

1.  Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study.

Authors:  Matthew A Weir; David N Juurlink; Tara Gomes; Muhammad Mamdani; Daniel G Hackam; Arsh K Jain; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

Review 2.  Beta-adrenoceptor blockade and exercise. An update.

Authors:  M A Van Baak
Journal:  Sports Med       Date:  1988-04       Impact factor: 11.136

3.  Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.

Authors:  L Gullestad; K Birkeland; G Nordby; S Larsen; J Kjekshus
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

4.  Effect of exercise intensity on potassium balance in muscle and blood of man.

Authors:  N K Vøllestad; J Hallén; O M Sejersted
Journal:  J Physiol       Date:  1994-03-01       Impact factor: 5.182

5.  Exercise tolerance with nebivolol and atenolol.

Authors:  L M Van Bortel; M A van Baak
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

6.  Lactate and H+ effluxes from human skeletal muscles during intense, dynamic exercise.

Authors:  J Bangsbo; L Johansen; T Graham; B Saltin
Journal:  J Physiol       Date:  1993-03       Impact factor: 5.182

7.  Effects of terbutaline on basal thermogenesis of human skeletal muscle and Na-K pump after 1 week of oral use--a placebo controlled comparison with propranolol.

Authors:  B Fagher; H Liedholm; A Sjögren; M Monti
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

Review 8.  Potassium regulation during exercise and recovery.

Authors:  M I Lindinger; G Sjøgaard
Journal:  Sports Med       Date:  1991-06       Impact factor: 11.136

Review 9.  Diuretic therapy and exercise performance.

Authors:  J E Caldwell
Journal:  Sports Med       Date:  1987 Jul-Aug       Impact factor: 11.136

10.  Lack of influence of short-term treatment with propranolol and terbutaline on metabolism and energy expenditure of the Na-K pump in human erythrocytes evaluated by microcalorimetry.

Authors:  B Fagher; H Liedholm; M Monti
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.